Works matching IS 09509232 AND DT 2011 AND VI 30 AND IP 22

Results: 10

Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells.

Published in:

Oncogene, 2011, v. 30, n. 22, p. 2514, doi. 10.1038/onc.2010.631

By:

Merlin, J;
Stechly, L;
de Beaucé, S;
Monté, D;
Leteurtre, E;
van Seuningen, I;
Huet, G;
Pigny, P

Publication type:

Article

IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.

Published in:

Oncogene, 2011, v. 30, n. 22, p. 2558, doi. 10.1038/onc.2010.627

By:

Cheong, J K;
Hung, N T;
Wang, H;
Tan, P;
Voorhoeve, P M;
Lee, S H;
Virshup, D M

Publication type:

Article

Targeting SET/I<sub>2</sub>PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy.

Published in:

Oncogene, 2011, v. 30, n. 22, p. 2504, doi. 10.1038/onc.2010.622

By:

Switzer, C H;
Cheng, R Y S;
Vitek, T M;
Christensen, D J;
Wink, D A;
Vitek, M P

Publication type:

Article

The Hsp90 inhibitor IPI-504 rapidly lowers EML4-ALK levels and induces tumor regression in ALK-driven NSCLC models.

Published in:

Oncogene, 2011, v. 30, n. 22, p. 2581, doi. 10.1038/onc.2010.625

By:

Normant, E;
Paez, G;
West, K A;
Lim, A R;
Slocum, K L;
Tunkey, C;
McDougall, J;
Wylie, A A;
Robison, K;
Caliri, K;
Palombella, V J;
Fritz, C C

Publication type:

Article

Loss of the Birt-Hogg-Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcription.

Published in:

Oncogene, 2011, v. 30, n. 22, p. 2534, doi. 10.1038/onc.2010.628

By:

Cash, T P;
Gruber, J J;
Hartman, T R;
Henske, E P;
Simon, M C

Publication type:

Article

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer.

Published in:

Oncogene, 2011, v. 30, n. 22, p. 2547, doi. 10.1038/onc.2010.626

By:

Serra, V;
Scaltriti, M;
Prudkin, L;
Eichhorn, P J A;
Ibrahim, Y H;
Chandarlapaty, S;
Markman, B;
Rodriguez, O;
Guzman, M;
Rodriguez, S;
Gili, M;
Russillo, M;
Parra, J L;
Singh, S;
Arribas, J;
Rosen, N;
Baselga, J

Publication type:

Article

Myc overexpression brings out unexpected antiapoptotic effects of miR-34a.

Published in:

Oncogene, 2011, v. 30, n. 22, p. 2587, doi. 10.1038/onc.2010.634

By:

Sotillo, E;
Laver, T;
Mellert, H;
Schelter, J M;
Cleary, M A;
McMahon, S;
Thomas-Tikhonenko, A

Publication type:

Article

Regulation of transcription of hypoxia-inducible factor-1α (HIF-1α) by heat shock factors HSF2 and HSF4.

Published in:

Oncogene, 2011, v. 30, n. 22, p. 2570, doi. 10.1038/onc.2010.623

By:

Chen, R;
Liliental, J E;
Kowalski, P E;
Lu, Q;
Cohen, S N

Publication type:

Article

MiniSOX9, a dominant-negative variant in colon cancer cells.

Published in:

Oncogene, 2011, v. 30, n. 22, p. 2493, doi. 10.1038/onc.2010.621

By:

Abdel-Samad, R;
Zalzali, H;
Rammah, C;
Giraud, J;
Naudin, C;
Dupasquier, S;
Poulat, F;
Boizet-Bonhoure, B;
Lumbroso, S;
Mouzat, K;
Bonnans, C;
Pignodel, C;
Raynaud, P;
Fort, P;
Quittau-Prévostel, C;
Blache, P

Publication type:

Article

ATR mediates cisplatin resistance in a p53 genotype-specific manner.

Published in:

Oncogene, 2011, v. 30, n. 22, p. 2526, doi. 10.1038/onc.2010.624

By:

Sangster-Guity, N;
Conrad, B H;
Papadopoulos, N;
Bunz, F

Publication type:

Article